|
Index | - | P/E | - | EPS (ttm) | - | Insider Own | - | Shs Outstand | - | Perf Week | -2.25% |
Market Cap | - | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | - | Perf Month | -4.00% |
Income | - | PEG | - | EPS next Q | - | Inst Own | - | Short Float | - | Perf Quarter | 0.15% |
Sales | - | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | - | Perf Half Y | 2.14% |
Book/sh | - | P/B | - | EPS next Y | - | ROA | - | Target Price | - | Perf Year | 11.87% |
Cash/sh | - | P/C | - | EPS next 5Y | - | ROE | - | 52W Range | 16.78 - 24.19 | Perf YTD | -3.11% |
Dividend | 0.18 | P/FCF | - | EPS past 5Y | - | ROI | - | 52W High | -4.67% | Beta | - |
Dividend % | 0.78% | Quick Ratio | - | Sales past 5Y | - | Gross Margin | - | 52W Low | 37.46% | ATR | 0.23 |
Employees | - | Current Ratio | - | Sales Q/Q | - | Oper. Margin | - | RSI (14) | 29.07 | Volatility | 1.24% 0.84% |
Optionable | Yes | Debt/Eq | - | EPS Q/Q | - | Profit Margin | - | Rel Volume | 1.62 | Prev Close | 23.55 |
Shortable | Yes | LT Debt/Eq | - | Earnings | - | Payout | - | Avg Volume | 299.32K | Price | 23.06 |
Recom | - | SMA20 | -2.88% | SMA50 | -3.03% | SMA200 | 2.76% | Volume | 485,777 | Change | -2.08% |
![]() | |||||||
![]() | |||||||
|
|||||||
![]() | |||||||
The investment seeks generate positive returns during periods of economic growth, preserve capital during periods of economic contraction, and preserve real rates of return during periods of heightened inflation. The fund is an actively-managed exchange-traded fund that seeks to achieve its investment objective primarily by investing across a variety of asset classes, including exposure to global equity securities, U.S. Treasury securities, and commodities. It's investment adviser seeks to invest the fund's assets to achieve exposures similar to those of the Advanced Research Risk Parity Index. The fund is non-diversified. | |||||||
![]() | |||||||
![]() |
open in yahoo | open in google |
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite